These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9853986)

  • 1. Comparison of four immunoassays for the detection of lorazepam in urine.
    Meatherall R; Fraser AD
    Ther Drug Monit; 1998 Dec; 20(6):673-5. PubMed ID: 9853986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEDIA dau Benzodiazepine screening assay: a reformulation.
    Meatherall RC; Fraser AD
    J Anal Toxicol; 1998; 22(4):270-3. PubMed ID: 9681328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine screening using EMIT II and TDx: urine hydrolysis pretreatment required.
    Meatherall R
    J Anal Toxicol; 1994; 18(7):385-90. PubMed ID: 7861751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
    Fraser AD; Meatherall R
    J Anal Toxicol; 1996; 20(4):217-23. PubMed ID: 8835658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of benzodiazepine intake in therapeutic doses by immunoanalysis of urine: two techniques evaluated and modified for improved performance.
    Beck O; Lafolie P; Hjemdahl P; Borg S; Odelius G; Wirbing P
    Clin Chem; 1992 Feb; 38(2):271-5. PubMed ID: 1541010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine.
    Fraser AD; Howell P
    J Anal Toxicol; 1998; 22(1):50-4. PubMed ID: 9491969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.
    Beck O; Lin Z; Brodin K; Borg S; Hjemdahl P
    J Anal Toxicol; 1997; 21(7):554-7. PubMed ID: 9399125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography- mass spectrometry.
    Klette KL; Wiegand RF; Horn CK; Stout PR; Magluilo J
    J Anal Toxicol; 2005 Apr; 29(3):193-200. PubMed ID: 15842763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
    Darragh A; Snyder ML; Ptolemy AS; Melanson S
    Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved cross-reactivity to alpha OH triazolam in the BMC CEDIA DAU urine benzodiazepine assay.
    Fraser AD; Meatherall R
    Ther Drug Monit; 1998 Jun; 20(3):331-4. PubMed ID: 9631932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the CEDIA and EMIT II immunoassays for the determination of benzodiazepines.
    Way BA; Walton KG; Koenig JW; Eveland BJ; Scott MG
    Clin Chim Acta; 1998 Mar; 271(1):1-9. PubMed ID: 9564553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening.
    Armbruster DA; Schwarzhoff RH; Hubster EC; Liserio MK
    Clin Chem; 1993 Oct; 39(10):2137-46. PubMed ID: 8403399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening.
    Armbruster DA; Hubster EC; Kaufman MS; Ramon MK
    Clin Chem; 1995 Jan; 41(1):92-8. PubMed ID: 7813088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the rates of hydrolysis of lorazepam-glucuronide, oxazepam-glucuronide and tamazepam-glucuronide catalyzed by E. coli beta-D-glucuronidase using the on-line benzodiazepine screening immunoassay on the Roche/Hitachi 917 analyzer.
    Dou C; Bournique JS; Zinda MK; Gnezda M; McNally AJ; Salamone SJ
    J Forensic Sci; 2001 Mar; 46(2):335-40. PubMed ID: 11305436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of several immunoassays used in drugs of abuse screening: Assessment against gold standard methods and calculation of measurement uncertainty.
    Mina A
    J Pharmacol Toxicol Methods; 2020; 101():106649. PubMed ID: 31730939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
    Valentine JL; Middleton R; Sparks C
    J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays--a comparative study.
    Bogusz M; Aderjan R; Schmitt G; Nadler E; Neureither B
    Forensic Sci Int; 1990 Nov; 48(1):27-37. PubMed ID: 2279719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of assay methods for benzodiazepines in urine. A receptor assay, two immunoassays, and gas chromatography-mass spectrometry.
    Nishikawa T; Ohtani H; Herold DA; Fitzgerald RL
    Am J Clin Pathol; 1997 Mar; 107(3):345-52. PubMed ID: 9052386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methaqualone excretion patterns using Abuscreen ONLINE and EMIT II immunoassays and GC/MS.
    Brenner C; Hui R; Passarelli J; Wu R; Brenneisen R; Bracher K; ElSohly MA; Ghodoussi VD; Salamone SJ
    Forensic Sci Int; 1996 May; 79(1):31-41. PubMed ID: 8635771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.